Article
Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study.
Annals of internal medicine - 15 May 2001
Sethi A A, Tybjaerg-Hansen A, Grønholdt M L, Steffensen R, Schnohr P, Nordestgaard B G
Abstract excerpt
BACKGROUND: The M235T and T174M angiotensinogen mutations have been linked to increased risk for ischemic heart and cerebrovascular disease. OBJECTIVE: To determine whether angiotensinogen mutations are associated with ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. DESIGN: Six case-control studies from the Copenhagen City Heart Study. SETTING: Copenhagen, Denmark....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.